Todd Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 19,754 shares at $17.54 ($346K) on 2025-09-08, disclosed to the SEC on 2025-09-10.
Scheduled sale ($346k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.54 | 9,625 | $169K | 48.7% |
| 2 | $17.54 | 9,625 | $169K | 48.7% |
| 3 | $17.52 | 504 | $9K | 2.5% |
| Total | $17.54 avg | 19,754 | $346K | 100% |
| Filing → |
| ARQT | SELL | 2026-03-03 | $1.9M | — | Filing → |
| ARQT | SELL | 2026-02-04 | $506K | — | Filing → |
| ARQT | SELL | 2025-11-24 | $3.0M | — | Filing → |